127P Real-world evidence and clinical characteristics in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI)

Iranzo, Patricia; Callejo, Ana; Marmolejo, David; Assaf, J.D.; Pardo, Núria; Navarro, Alejandro; Martínez‐Martí, Alex; Cedrés, S.; Mejia, N.M. Diaz; Carbonell, Caterina

doi:10.1016/s1556-0864(21)01969-9

127P Real-world evidence and clinical characteristics in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI)

NobleIDNI1P19W20R76S71

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C570B531.svg?ark=w1%2F20260521%2FC570B531&value=id)](https://nobleid.org/work/w1/20260521/C570B531)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

127P Real-world evidence and clinical characteristics in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI)

NobleIDNI1P19W20R76S71

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C570B531.svg?ark=w1%2F20260521%2FC570B531&value=id)](https://nobleid.org/work/w1/20260521/C570B531)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work